MENU
+Compare
AMLX
Stock ticker: NASDAQ
AS OF
Sep 3 closing price
Price
$9.84
Change
-$0.14 (-1.40%)
Capitalization
876.96M

AMLX Amylyx Pharmaceuticals Forecast, Technical & Fundamental Analysis

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases... Show more

AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AMLX with price predictions
Sep 02, 2025

Momentum Indicator for AMLX turns positive, indicating new upward trend

AMLX saw its Momentum Indicator move above the 0 level on August 21, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 58 similar instances where the indicator turned positive. In of the 58 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for AMLX just turned positive on August 22, 2025. Looking at past instances where AMLX's MACD turned positive, the stock continued to rise in of 31 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where AMLX advanced for three days, in of 220 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 140 cases where AMLX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMLX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AMLX broke above its upper Bollinger Band on August 22, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AMLX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.225) is normal, around the industry mean (19.852). P/E Ratio (2.814) is within average values for comparable stocks, (51.814). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.136). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (3.627) is also within normal values, averaging (322.082).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

AMLX is expected to report earnings to -45 cents per share on November 06

Amylyx Pharmaceuticals AMLX Stock Earnings Reports
Q3'25
Est.
$-0.46
Q2'25
Est.
$-0.46
Q1'25
Beat
by $0.20
Q4'24
Beat
by $0.01
Q3'24
Missed
by $0.37
The last earnings report on August 07 showed earnings per share of -46 cents, meeting the estimate of -46 cents. With 1.64M shares outstanding, the current market capitalization sits at 876.96M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
43 Thorndike Street
Phone
+1 617 682-0917
Employees
384
Web
https://www.amylyx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WGUSX14.770.03
+0.20%
Wasatch US Select Inst
CMGIX42.310.07
+0.17%
BlackRock Mid-Cap Growth Equity Instl
TSONX15.44N/A
N/A
Nuveen International Res Eq R6
SJGIX32.76N/A
N/A
Steward Large Cap Growth I
LGOFX31.33-0.01
-0.03%
Lord Abbett Growth Opportunities F

AMLX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been loosely correlated with GRI. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if AMLX jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
-1.40%
GRI - AMLX
57%
Loosely correlated
+4.29%
SLRX - AMLX
54%
Loosely correlated
-3.42%
RGNX - AMLX
46%
Loosely correlated
+8.11%
ADVM - AMLX
44%
Loosely correlated
+6.91%
LRMR - AMLX
44%
Loosely correlated
+6.20%
More